On Monday, Vera Therapeutics Inc (NASDAQ: VERA) opened lower -2.15% from the last session, before settling in for the closing price of $48.31. Price fluctuations for VERA have ranged from $12.28 to $51.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -25.63% at the time writing. With a float of $46.84 million, this company’s outstanding shares have now reached $63.32 million.
The firm has a total of 51 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vera Therapeutics Inc (VERA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vera Therapeutics Inc is 26.04%, while institutional ownership is 77.46%. The most recent insider transaction that took place on Nov 25 ’24, was worth 936,006. Before that another transaction happened on Nov 13 ’24, when Company’s PRESIDENT AND CEO sold 30,625 for $49.50, making the entire transaction worth $1,516,037. This insider now owns 85,942 shares in total.
Vera Therapeutics Inc (VERA) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.58 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.51) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.63% per share during the next fiscal year.
Vera Therapeutics Inc (NASDAQ: VERA) Trading Performance Indicators
Check out the current performance indicators for Vera Therapeutics Inc (VERA). In the past quarter, the stock posted a quick ratio of 13.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -3.14 in one year’s time.
Technical Analysis of Vera Therapeutics Inc (VERA)
Analysing the last 5-days average volume posted by the [Vera Therapeutics Inc, VERA], we can find that recorded value of 0.53 million was lower than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 50.36%. Additionally, its Average True Range was 2.66.
During the past 100 days, Vera Therapeutics Inc’s (VERA) raw stochastic average was set at 75.78%, which indicates a significant increase from 47.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.75% in the past 14 days, which was lower than the 54.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.62, while its 200-day Moving Average is $40.74. Now, the first resistance to watch is $48.98. This is followed by the second major resistance level at $50.69. The third major resistance level sits at $51.90. If the price goes on to break the first support level at $46.05, it is likely to go to the next support level at $44.84. Should the price break the second support level, the third support level stands at $43.13.
Vera Therapeutics Inc (NASDAQ: VERA) Key Stats
There are currently 63,323K shares outstanding in the company with a market cap of 2.99 billion. Presently, the company’s annual sales total 0 K according to its annual income of -95,990 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -46,630 K.
